Add time:08/25/2019         Source:sciencedirect.com

A series of anilinophthalazine derivatives 4a–j was initially synthesized and tested for its VEGFR-2 inhibitory activity where it showed promising activity (IC50 = 0.636–5.76 μM). Molecular docking studies guidance was used to improve the binding affinity for series 4a–j towards VEGFR-2 active site. This improvement was achieved by increasing the hydrophobic interaction with the hydrophobic back pocket of the VEGFR-2 active site lined with the hydrophobic side chains of Ile888, Leu889, Ile892, Val898, Val899, Leu1019 and Ile1044. Increasing the hydrophobic interaction was accomplished by extending the anilinophthalazine scaffold with a substituted phenyl moiety through an uriedo linker which should give this extension the flexibility required to accommodate itself deeply into the hydrophobic back pocket. As planned, the designed uriedo-anilinophthalazines 7a–i showed superior binding affinity than their anilinophthalazine parents (IC50 = 0.083–0.473 μM). In particular, compounds 7g–i showed IC50 of 0.086, 0.083 and 0.086 μM, respectively, which are better than that of the reference drug sorafenib (IC50 = 0.09 μM).

We also recommend Trading Suppliers and Manufacturers of 2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE (cas 113772-12-6). Pls Click Website Link as below: cas 113772-12-6 suppliers